Pharmaust Limited's market cap is currently ―. The company's EPS TTM is AU$-0.02; its P/E ratio is -15.69; Pharmaust Limited is scheduled to report earnings on August 30, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 2.42M	AU$ 3.02M	AU$ 2.88M	AU$ 2.09M	AU$ 1.88M
Total Assets	AU$ 10.08M	AU$ 10.95M	AU$ 10.75M	AU$ 8.60M	AU$ 8.36M
Total Debt	AU$ 1.39M	AU$ 1.28M	AU$ 1.47M	AU$ 324.61K	AU$ 425.64K
Net Debt	AU$ -1.03M	AU$ -1.74M	AU$ -1.41M	AU$ -1.77M	AU$ -1.45M
Total Liabilities	AU$ 2.23M	AU$ 2.07M	AU$ 2.22M	AU$ 1.14M	AU$ 1.22M
Stockholders Equity	AU$ 7.84M	AU$ 8.88M	AU$ 8.53M	AU$ 7.46M	AU$ 7.14M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Pharmaust Limited Earnings and Revenue History

Income Statement >

Pharmaust Limited Debt to Assets

Balance Sheet >

Pharmaust Limited Cash Flow

Cash Flow >

Pharmaust Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing